Prelude Therapeutics Incorporated (PRLD) ownership: Top institutional holder: ORBIMED ADVISORS LLC ($37.31M). Insider activity: Net Seller (0 buys, 7 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10909256.00 | $37.31M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 10123824.00 | $34.62M | 2026-03-31 |
| Kynam Capital Management, LP | 1592551.00 | $5.45M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1230406.00 | $4.21M | 2026-03-31 |
| VANGUARD GROUP INC | 1413986.00 | $4.10M | 2025-12-31 |
| EcoR1 Capital, LLC | 947049.00 | $3.24M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 923626.00 | $3.16M | 2026-03-31 |
| SPHERA FUNDS MANAGEMENT LTD. | 558339.00 | $1.91M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-04-21 | |
| Sell | null | 2026-04-21 | |
| Sell | null | 2026-02-04 | |
| Sell | null | 2026-02-04 | |
| Sell | null | 2026-02-04 | |
| Sell | null | 2026-02-04 |
Back to PRLD overview · PRLD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.